ArticleCancers2023

MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML.

Katrin Teich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.